Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02558491 · ClinicalTrials.gov registry record · NA
Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM
A NA study, sponsored by Daniel Chernavvsky, MD.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT02558491 is a NA study that has completed, run by Daniel Chernavvsky, MD. The registered enrollment target is 33 participants.
The verdict
NCT02558491, a NA study, has completed, sponsored by Daniel Chernavvsky, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and feasibility of a decision support system aimed at reducing glucose variability in T1DM patient using an insulin pump.
Interventions
- OTHER Usual Care
- DEVICE Decision Support System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02558491
The ClinicalTrials.gov registry entry for NCT02558491 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daniel Chernavvsky, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02558491 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02558491 about?
NCT02558491 is a clinical study titled "Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM". The purpose of this study is to demonstrate the safety and feasibility of a decision support system aimed at reducing glucose variability in T1DM patient using an insulin pump.
What is the current status of trial NCT02558491?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2015-09. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02558491?
The interventions under investigation include: Usual Care (OTHER), Decision Support System (DEVICE).
Who is sponsoring clinical trial NCT02558491?
This trial is sponsored by Daniel Chernavvsky, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.